We are live on ! Find out more
GEN

Genesis Healthcare, Inc.
GEN

Delisted

GEN was delisted on the 25th of March, 2021.

Back to rankings

1 hedge funds and large institutions have $0 invested in Genesis Healthcare, Inc. in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

100% less capital invested

Capital invested by funds: $1 → $0 (-$1)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

GEN Hedge Fund Activity: Q4 2023 in Review

1 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q4 2023, worth a combined $0 — down 100% from $1 a quarter earlier.

Fund positioning in GEN was balanced in Q4 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Genesis Healthcare, Inc. (GEN) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $0 of Genesis Healthcare, Inc. stock for Q4 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Genesis Healthcare, Inc. positions in Q4 2023 and 0 closed out.

Based on aggregated 13F filings for Q4 2023.